KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation and Depletion (2016 - 2026)

Pacific Biosciences Of California has reported Depreciation and Depletion over the past 16 years, most recently at $2.7 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 4.15% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $13.0 million, down 5.8%, while the annual FY2025 figure was $13.0 million, 5.8% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $2.7 million at Pacific Biosciences Of California, up from $2.5 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $5.1 million in Q1 2025 and troughed at $1.6 million in Q2 2021.
  • A 5-year average of $2.8 million and a median of $2.7 million in 2025 define the central range for Depreciation and Depletion.
  • On a YoY basis, Depreciation and Depletion climbed as much as 58.36% in 2025 and fell as far as 41.31% in 2025.
  • Year by year, Depreciation and Depletion stood at $2.3 million in 2021, then increased by 13.61% to $2.6 million in 2022, then increased by 16.11% to $3.0 million in 2023, then fell by 3.63% to $2.9 million in 2024, then fell by 4.15% to $2.7 million in 2025.
  • Business Quant data shows Depreciation and Depletion for PACB at $2.7 million in Q4 2025, $2.5 million in Q3 2025, and $2.7 million in Q2 2025.